Oncology & Cancer

Cancer immunotherapy: Revived T cells still need fuel

Anti-cancer drugs blocking the PD-1 pathway - known as checkpoint inhibitors - are now FDA-approved for melanoma, lung cancer and several other types of cancer. These drugs are often described as "releasing the brakes" on ...

Medical research

Between B cells and T cells

Mature cells develop through a number of immature stages. During this process, they must remember the specialization they are committed to. For immune system B cells, Rudolf Grosschedl of the Max Planck Institute of Immunobiology ...

Oncology & Cancer

Scientists shine new light on link between obesity and cancer

Scientists have made a major discovery that shines a new, explanatory light on the link between obesity and cancer. Their research confirms why the body's immune surveillance systems—led by cancer-fighting Natural Killer ...

Diabetes

Antibody holds promise for treatment of type 1 diabetes

Type 1 diabetes, which usually appears in children and adolescents, affects over 30 million people worldwide. Resulting from an auto-immune reaction that destroys the pancreatic beta cells that produce insulin, the disease ...

Oncology & Cancer

Natural kill cell technology to stop cancer gets licensed

Our bodies contain Natural Killer (NK) cells - an army that stops cancers and viruses before they can make us sick. A researcher from the University of Central Florida's College of Medicine has created a nanoparticle that ...

Immunology

Does running a marathon suppress your immune system?

It is commonly believed that some forms of exercise, such as endurance events, suppress your immune system and leave you at risk of infections, like the common cold. However, our latest review of the evidence suggests that ...

page 7 from 40